Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0SH3I
|
||||
Former ID |
DAP001318
|
||||
Drug Name |
Bortezomib
|
||||
Synonyms |
DPBA; PROSCRIPT BORONIC ACID; LPD 341; LDP-341; LPD-341; PS-341; VELCADE (TN); Velcade (TN); Pyz-Phe-boroLeu; Bortezomib(JAN/USAN/INN); Velcade, MG-341, PS-341, Bortezomib; [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid; N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; Bortezomib (Proteasome inhibitor)
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Takeda
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H25BN4O4
|
||||
InChI |
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
|
||||
InChIKey |
GXJABQQUPOEUTA-RDJZCZTQSA-N
|
||||
CAS Number |
CAS 179324-69-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
518755, 600019, 10276517, 11433362, 12015194, 14853748, 17137090, 17397304, 46508736, 50726119, 53787350, 56311715, 56311812, 56312401, 56313329, 56314055, 56314414, 56314469, 56314470, 57402302, 85096715, 87325438, 91611228, 99432365, 99443946, 103338073, 103963945, 104603020, 118048485, 118318599, 121360388, 124756934, 124950705, 125163741, 134340388, 135696579, 136023422, 136342479, 136367512, 136920302, 137030372, 141858114, 143497187, 144206183, 144206225, 152049125, 152239004, 152344341, 160829216, 160968549
|
||||
ChEBI ID |
ChEBI:52717
|
||||
SuperDrug ATC ID |
L01XX32
|
||||
SuperDrug CAS ID |
cas=179324697
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | Proteasome | Target Info | Modulator | [556264] | |
References | |||||
Ref 537129 | New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. | ||||
Ref 541528 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6391). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.